Evidence map›Paper›PMID 29052526›Full record

ReviewJournal of medical case reports2017

Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by

S C Sasson, R Russo, T Chung, G Chu, I Hunyor, J Williamson, A Murad, A Kane, S Riminton, S Limaye

Open access · goldAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of medical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Ventricular fibrillation as an initial manifestation of cardiac sarcoidosis.Proceedings (Baylor University. Medical Center) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

S C SassonDepartment of Clinical Immunology, Concord Hospital, Level 6, Hospital Rd, Concord, Sydney, NSW, 2139, Australia. ssas7805@med.usyd.edu.au.
R RussoDepartment of Nuclear Medicine, Concord Hospital, Sydney, Australia.
T ChungDepartment of Cardiology, Concord Hospital, Sydney, Australia.
G ChuDepartment of Immunology, Liverpool Hospital, Sydney, Australia.
I HunyorSydney Medical School, University of Sydney, Sydney, Australia.
J WilliamsonDepartment of Respiratory Medicine, Liverpool Hospital, Sydney, Australia.
A MuradDepartment of Immunology, Liverpool Hospital, Sydney, Australia.
A KaneDepartment of Immunology, Liverpool Hospital, Sydney, Australia.
S RimintonDepartment of Clinical Immunology, Concord Hospital, Level 6, Hospital Rd, Concord, Sydney, NSW, 2139, Australia.
S LimayeDepartment of Clinical Immunology, Concord Hospital, Level 6, Hospital Rd, Concord, Sydney, NSW, 2139, Australia.
Concord Repatriation General Hospital · AULiverpool Hospital · AURoyal Prince Alfred Hospital · AUSouth Western Sydney Local Health District · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcoidosis is an inflammatory disorder of immune dysregulation characterized by non-caseating granulomas that can affect any organ. Cardiac sarcoidosis is an under-recognized entity that has a heterogeneous presentation and may occur independently or with any severity of systemic disease. Diagnosing cardiac sarcoidosis remains problematic with endomyocardial biopsies associated with a high risk of complications. Several diagnostic algorithms are currently available that rely on histopathology or clinical and radiological measures. The dominant mode of diagnostic imaging to date for cardiac sarcoidosis has been cardiac magnetic resonance imaging with gadolinium enhancement. CASE PRESENTATIONS: We report the cases of two adult patients: case 1, a 50-year-old white man who presented with severe congestive cardiac failure; and case 2, a 37-year-old white woman who presented with complete heart block. Both patients had a background of untreated pulmonary sarcoidosis. Cardiac magnetic resonance imaging did not show evidence of sarcoidosis in either patient and both proceeded to

conclusionsCurrent consensus guidelines recommend all patients with sarcoidosis undergo screening for occult cardiac disease, with thorough history and examination, electrocardiogram, and transthoracic echocardiogram. If any abnormalities are detected, advanced cardiac imaging should follow. While cardiac magnetic resonance imaging identifies the majority of cardiac sarcoidosis, early disease may not be detected. These cases demonstrate

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsAdultCardiomyopathiesFemaleHeartHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographySarcoidosisFluorodeoxyglucose F18RadiopharmaceuticalsCardiac sarcoidosisCMRFDG-PET

Identifiers

PMID29052526
PMCPMC5649067
OpenAlexW2766973384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.